Healthcare
What pharma can learn from supermarkets about behaviour change
Supermarkets spend a fortune on behavioural design. Not on explaining why a particular yoghurt is healthier than the next one — they know shoppers don't read the label. On the floor plan, the shelf height, the lighting, the music, the order of the aisles, the position of the checkout.
They have accepted something pharma still often resists: that most decisions are not made deliberately, and the job of the environment is to make the good decision the easy one.
What this looks like in pharma
Most pharma brand teams still operate as if physicians are rational agents who weigh clinical evidence and choose the optimal therapy. They are not. Nobody is. A physician seeing thirty patients a day is running on heuristics, defaults, and whatever was in front of them most recently.
The question isn't "how do we persuade them". The question is "what is the environment around this decision, and what does it nudge them toward".
Three borrowed principles
1. Eye level is buy level
Supermarkets charge brands more for shelf positions at adult eye level. The equivalent in pharma is the default order set in the EMR, the first-line recommendation in the treatment algorithm, the guideline's summary box. These are eye-level positions. Most brand teams spend 95% of their effort on the end aisle display (congresses, campaigns) and 5% on the shelf position itself.
2. Reduce the number of decisions
Good supermarket design doesn't ask the shopper to make decisions they don't need to make. Pharma packaging, dosing complexity, and patient-support design often does the opposite. Every extra decision — for the physician, for the pharmacist, for the patient — is a friction point. Friction is cheaper than persuasion, but only if you design it in the right direction.
3. The checkout is where you fix experience
In retail, a lot of loyalty is won or lost in the last thirty seconds. In pharma, the equivalent is the first script, the first week of therapy, the first side effect call. Brand teams spend heavily on awareness and consideration; they often spend almost nothing on the checkout. That's backwards.
What we're not saying
Pharma isn't retail. Physicians aren't shoppers. Clinical decisions aren't grocery choices, and patient safety isn't a nudge problem. The point isn't that the tools are interchangeable.
The point is that an industry which has spent decades studying how humans actually choose — with far less money and far fewer stakeholders than pharma — has discovered something useful. Ignoring that because it didn't come out of clinical trials is a particular kind of mistake.